drugset / Trial / NCT06438757
Trial of JYB1904 in Patients With Allergic Asthma
RandomizedParallel-groupOpen-labelTreatment
Summary
This phase IIa trial is meant to evaluate the pharmacokinetics, pharmacodynamics and safety of JYB1904 in patients with allergic asthma.
Timeline
- Start
- 2024-06-19
- Primary completion
- 2025-11-20
- Completion
- 2025-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OZUREPRUBART | Monoclonal antibody | — | — |
| Comparator | Omalizumab | Monoclonal antibody | — | — |